Cargando…
Targeted co-delivery of Beclin 1 siRNA and FTY720 to hepatocellular carcinoma by calcium phosphate nanoparticles for enhanced anticancer efficacy
PURPOSE: FTY720, known as fingolimod, is a new immunosuppressive agent with effective anticancer properties. Although it was recently confirmed that FTY720 inhibits cancer cell proliferation, FTY720 can also induce protective autophagy and reduce cytotoxicity. Blocking autophagy with Beclin 1 siRNA...
Autores principales: | Wu, Jun-Yi, Wang, Zhong-Xia, Zhang, Guang, Lu, Xian, Qiang, Guang-Hui, Hu, Wei, Ji, An-Lai, Wu, Jun-Hua, Jiang, Chun-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842779/ https://www.ncbi.nlm.nih.gov/pubmed/29551896 http://dx.doi.org/10.2147/IJN.S156328 |
Ejemplares similares
-
FTY720-derivatives do not induce FTY720-like lymphopenia
por: Segura-Ulate, Ismael, et al.
Publicado: (2017) -
FTY720 attenuates excitotoxicity and neuroinflammation
por: Cipriani, Raffaela, et al.
Publicado: (2015) -
The effect of the sphingosine‐1‐phosphate analogue FTY720 on atrioventricular nodal tissue
por: Egom, Emmanuel E., et al.
Publicado: (2015) -
Synthesis of Novel FTY720 Analogs with Anticancer Activity through PP2A Activation
por: Shrestha, Jitendra, et al.
Publicado: (2018) -
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
por: Alshaker, Heba, et al.
Publicado: (2017)